The rounds this investor is named on, who it invests beside, and where it shows up.
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
SpliceBio SpliceBio develops next-generation gene therapies using their proprietary Protein Splicing platform, targeting diseases caused by mutations in large genes. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $135M | 2025-06-11 | [ PART ] |
No sector on record.
Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $130M |
| 2025-05-27 |
| [ PART ] |